FDA Advisers Recommend Moderna’s COVID-19 Vaccine for Older Children

Vials of Moderna's COVID-19 vaccine in Bridgeport, Conn., in a file image. Joseph Prezioso/AFP via Getty Images

Advisers to the Food and Drug Administration (FDA) on June 14 recommended the agency grant emergency authorization to Moderna’s COVID-19 vaccine for children aged 6 to 17.

The advisory panel was asked whether they believe the benefits of the vaccine outweigh the risks, and unanimously voted yes following an eight-hour virtual meeting.